Physician profile
Van B Boggus
NPI 1326153925
$6,935.20
in general payments reported to CMS, 2019-2025
19 companies · $728 in 2025
The $728 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,539 · 2020: $265 · 2021: $588 · 2022: $598 · 2023: $2,402 · 2024: $814 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,731 · Travel and Lodging: $1,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,730.80 |
| Travel and Lodging | $1,214.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,855.13 | 2021-2025 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Amgen INC. | $1,372.12 | 2019-2025 | Evenity, Prolia |
| Medtronic USA, INC. | $550.07 | 2019-2020 | |
| Radius Health, INC. | $503.92 | 2019-2025 | Tymlos |
| Heron Therapeutics, INC. | $125.00 | 2022 | |
| Ferring Pharmaceuticals INC. | $73.78 | 2019 | |
| Stryker Corporation | $67.71 | 2019-2023 | Hoffmann |
| Daiichi Sankyo INC. | $58.43 | 2019 | |
| Smith+Nephew, INC. | $58.26 | 2019-2023 | Stravix, Grafix Pl |
| Depuy Synthes Sales INC. | $51.50 | 2019-2024 | Gii, Dynatape, Dynacord |
| Orthofix Medical, INC. | $48.60 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $34.07 | 2024-2025 | |
| Pfizer INC. | $27.08 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $25.68 | 2024 | Zilretta, Iovera, Exparel |
| Paratek Pharmaceuticals, INC. | $20.07 | 2024 | Nuzyra |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $19.08 | 2025 | |
| Integra Lifesciences Corporation | $18.76 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.44 | 2023 | Seglentis |
| Sanofi-Aventis U.S. LLC | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Van Boggus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.